Using reduction of viral RNA copies as biomarker available across all animal models and human patients, we demonstrate that molnupiravir, but not paxlovid, prevents all SARS-CoV-2 transmission when ...

(UPDATED) Treating patients with atherosclerotic cardiovascular disease (ASCVD) with low-dose aspirin is just as effective as using the 325-mg dose for the prevention of major cardiovascular events, ...

Tree shrew (Tupaia belangeri) is a promising experimental animal in biomedical research, but the equivalent doses of drugs between tree shrew and human and other animals has not been explored, which ...

Botswana's health minister said on Friday that the government was paying the equivalent of $15 a dose for the COVID-19 vaccine developed by China's Sinovac Biotech and almost $29 a dose for U.S.

Table I shows the simulation results for predicted post-conversion VPA minimum concentration (C min), maximum concentration (C max) and the percentage of patients predicted to have plasma VPA C min ...

ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...

Correction to the article “Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis: Pathophysiology, Diagnosis, and the Evolving Treatment Landscape” published in a September 2021 supplement to The ...

Georgia State University. "Molnupiravir administered at human effect size-equivalent dose blocks SARS-CoV-2 transmission in ferrets, researchers find." ScienceDaily. ScienceDaily, 14 August 2023. <www ...

GABORONE, July 30 (Reuters) - Botswana's health minister said on Friday that the government was paying the equivalent of $15 a dose for the COVID-19 vaccine developed by China's Sinovac Biotech and ...

ATLANTA—Two oral drugs, molnupiravir and paxlovid (nirmatrelvir/ritonavir), provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models ...